T. W. HART - Concepedia

Author

T. W. HART

Novartis (Switzerland)

Also Known As

T. W. HART, T. W. Hart, T.W. Hart, Terance Hart, Terance W. Hart

Publications

895

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Baker Engineering (United States)Granta Design (United Kingdom)Barking and Dagenham College Novartis (Japan)

About

T. W. HART is an author at Novartis (Switzerland) specializing in pharmacology, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	10	10	650
2	Natural Sciences	9	9	606
3	Medicine	8	8	221
4	Engineering	3	3	104
5	Health Sciences	1	1	59

T. W. HART

Publications

862

Citations

H-Index

Page 1

	Year	Citations
Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione T. W. HART Tetrahedron Letters Derivative (Chemistry)Bioorganic ChemistryDerivativesBiochemistryNatural Sciences	1985	395
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB<sub>1</sub>/CB<sub>2</sub>Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration Edward K. Dziadulewicz, Stuart Bevan, Christopher T. Brain, Journal of Medicinal Chemistry	2007	96
Identification and Biological Characterization of 6-Aryl-7-isopropylquinazolinones as Novel TRPV1 Antagonists that Are Effective in Models of Chronic Pain Andrew J. Culshaw, Stuart Bevan, Martin Lau Christiansen, Journal of Medicinal Chemistry Pain TherapyNovel Trpv1Pain MedicineTrpv1 AntagonistsHigh Throughput	2005	59
Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization Nicholas G. Davies, Helen Browne, Ben Davis, Bioorganic & Medicinal Chemistry Drug TargetMedicineNatural SciencesPharmacologyRational Drug Design	2012	45
Total synthesis of (±)-prostagladin D<sub>1</sub>: use of triethylsilyl protecting groups T. W. HART, David A. Metcalfe, Feodor Scheinmann Journal of the Chemical Society Chemical Communications DerivativesBioorganic ChemistryBiochemistryEngineering-Prostaglandin D1	1979	39
Synthesis and biological activity of trans-(.+-.)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogs: a new class of potassium channel opener Thomas J. Brown, Robert F. Chapman, David Cook, Journal of Medicinal Chemistry Bioorganic ChemistryEngineeringOrganic ChemistryHeterocycle ChemistryChemical Biology	1992	38
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas T. W. HART, Alba T. Macias, Karen Benwell, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineChiral Azetidine UreasSurprising SelectivityHydrolase Inhibitors	2009	30
Regioselective epoxide-carbonyl rearrangements: A ring enlargement of cyclobutanones to cyclopentanones. T. W. HART, M.‐T. COMTE Tetrahedron Letters EngineeringHeterocyclicBiochemistryNatural SciencesDiversity-oriented Synthesis	1985	27
Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-Cyanopyrimidines. Part 2 Osamu Irie, Takatoshi Kosaka, Masashi Kishida, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPharmacologyNeuropharmacologyPharmacotherapyDrug Development	2008	24
The synthesis of RP 65479 a novel, potent potassium channel opener. T. W. HART, D. Guillochon, Guy Perrier, Tetrahedron Letters Molecular PharmacologyBiochemistryMedicineDrug DiscoveryNatural Sciences	1992	23

Page 1